Company Overview and News

12
3
Cheniere Energy Partners: Is It Worth The Money To Invest In This Energy Stock?

2018-07-20 seekingalpha
Cheniere Energy Partners LP (CQP) is a Delaware-based subsidiary of Cheniere Energy Inc. (NYSEMKT:LNG) and is engaged in the development, construction, and operation of liquefaction facilities adjacent to the Sabine Pass LNG Terminal. Its operations are based in Louisiana where it operates the Sabine Pass LNG receiving terminal and Creole Trail Pipeline through its wholly owned subsidiaries.
CQP RDS.B RDS.A LNG RYDBF RDSB RDSA RYDAF

0
CQP / Cheniere Energy Partners, LP S-4

2018-07-18 sec.gov
S-4 Table of Contents As filed with the Securities and Exchange Commission on July 18, 2018 Registration No. 333-
CQP

2
‘Bridge to Nowhere’ Leaves Pent-Up Permian Gas Problems Unsolved - Bloomberg

2018-07-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SRE.PRA CQP LNG SRE

18
Here's Why You Should Add Plains All American Pipeline Now

2018-07-18 zacks
Estimates for Plains All American Pipeline, L.P. (PAA - Free Report) have been revised upward over the past 60 days, reflecting analysts’ optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings have moved up 7% and 8% to $1.52 and $1.88, respectively. Plains All American Pipeline is a master limited partnership based in Houston, TX. It is involved in the transportation, storage, terminalling and marketing of crude oil, natural gas, natural gas liquids (NGL) and refined products in the United States and Canada.
GEC GE CQP LNG DVN MUR.WI GNE MUR PAA

2
Subliminal LNG Marketing

2018-07-17 seekingalpha
Anyone who watches late night TV knows the modus operandi of the “pitchman” who hawks products typically with a fast-talking, got-to-have-it style. These people exist because they are highly effective sale people who understand how to push the right buttons with viewers that will make them pick up the phone, or sign onto their computers to order the product that will eventually wind up sitting in a drawer or the back of a closet.
CQP LNG

43
Natural Gas Falls Despite Bullish Inventory Data: Here's Why

2018-07-16 zacks
The U.S. Energy Department's weekly inventory release showed a smaller-than-expected increase in natural gas supplies. Despite the headline beat, bearish weather predictions pointed to weakening demand and pressured the fuel’s price, which lost around 4% for the week.
ECR CKRGZ POOL CQP LNG CHKVP CRK COG CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP GTT CHK CHK.WI CHK.PRD

2
MLPs Green With Anticipation

2018-07-15 seekingalpha
Midstream had a decent week, highlighted by the MLP Index outperforming U.S. and Canadian midstream corporations and breaking back into positive total return territory year to date. MLPs traded up despite weakness in commodity prices and in utilities. On Monday, in particular, MLP action was encouraging when the UTY was drubbed for a 3% loss and the MLP Index was positive.
NGL DCP CQP 7018 CME LNG EPD

2
Global Energy Advisory - 13th July, 2018

2018-07-13 oilprice
U.S. LNG producers are racing to add production capacity amid forecasts for strong growth in demand, with the total—concentrated in Louisiana and Texas—set to reach 10 billion cubic feet daily by the end of next year, from about 4 billion cubic feet a day today. And yet, all this capacity will not be enough to prevent the supply crunch that has been predicted by Shell.
CQP LNG

8
Oil Retraces On Libyan Production Surge

2018-07-13 oilprice
Tom majored in International Business at Amsterdam’s Higher School of Economics, he is now working as news editor for Oilprice.com.
IOC FP CQP RDS.B RDS.A LNG RDSB TOT 530965 RDSA COP 7018 CME ENGI CVX RYDBF RYDAF

11
Ferrellgas (FGP) Acquires Diamond Propane, Expands Operations

2018-07-13 zacks
Ferrellgas Partners L.P. (FGP - Free Report) announced the buyout of Diamond Propane, Inc, based in Potsdam, NY. Diamond Propane is a propane retailer that serves residential, agricultural, industrial and commercial customers in and around St. Lawrence County. The acquisition is expected to be immediately accretive to earnings and expand Ferrellgas’ operation in northern New York. Expansion via Acquisition Along with organic growth, Ferrellgas looks for strategic acquisitions of other propane operators to expand footprint across the United States.
CQP LNG DVN MUR.WI MUR FGP

4
Here's Why You Should Add Enphase Energy to Your Portfolio

2018-07-13 zacks
Earnings estimates for Enphase Energy, Inc (ENPH - Free Report) have been revised upward over the past 90 days, reflecting analyst’s optimism in the stock. The Zacks Consensus Estimate for 2018 and 2019 earnings moved up by 28.6% and 20% to 9 cents and 30 cents, respectively. Enphase Energy, based in Petaluma, CA, designs, develops and sells microinverter systems for residential as well as commercial markets in the United States and internationally.
CQP LNG DVN MUR.WI MUR ENPH SAM

2
Why The Future Of Energy Could Be U.S. Natural Gas

2018-07-13 seekingalpha
Geology dictates that crude oil and natural gas go hand-in-hand. Drill a well for one and there’s a good chance you’ll also find the other.
CQP 7018 CME LNG

2
Cheniere, CME Group's Futures Contract to Reshape LNG Space

2018-07-11 zacks
Cheniere Energy, Inc. (LNG - Free Report) recently agreed to work with CME Group Inc. (CME - Free Report) , one of the world's most diverse derivatives marketplaces, in order to create a futures contract for supplying liquefied natural gas ("LNG"). The deal, which will enable physical delivery of LNG produced in the United States, is expected to make the LNG market more transparent and liquid.
LMT CQP 7018 CME LNG LNG EOG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 16411Q101